NGM Clinical Study Site

Houston, Texas 77030

0 studies enrolling now · 4 studies all time

What they study most

Bladder Cancer, Bladder Urothelial Cancer, Breast Cancer, Cervical Cancer, Cholangiocarcinoma, Colorectal Cancer, Colorectal Carcinoma, Endocervical Cancer, Esophageal Cancer, Gastric Cancer, Glioblastoma, Head Neck Squamous Cell Carcinoma

Studies at this site

• Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) — Completed
• Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy — Completed
• Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors — Running, not enrolling
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies — Status unconfirmed